Welcome : Guest

OraSure Technologies, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about OraSure Technologies, Inc., which is principally involved in providing Oral Fluid Diagnostic Products and Specimen Collection Devices. Illustrated with 23 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-08910
Price: $1150
Company Type: Public
Pages: 25
Date: November 2016
Market Data Tables: 23

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: OraSure Technologies, Inc.’s Sales by Business Segment Worldwide (2014-2015) in Percentage for OSUR Business, and DNAG Business......3
Table 2: OraSure Technologies, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Europe, and Others......4
Drugs of Abuse Testing (DOA) Testing......5
Table 3: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......5
Hepatitis C Virus (HCV)......6
Table 4: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......6
Table 5: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......7
HIV ......8
Table 6: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......8
HIV Point-of-Care Testing......9
Table 7: HIV Point-of-Care Testing Market by Type in the US (2015) - Percentage Share Breakdown by Value for Chembio Blood, Orasure Blood, Orasure Saliva, and Others......9
HIV Regimens......10
Table 8: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......10
Table 9: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......11
Table 10: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......12
Immunoassay......13
Table 11: Immunoassay Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Allergy, Autoimmunity, Bone and Mineral, Cardiac markers, GI Stool Testing, Hepatitis and Retroviruses, Infectious Diseases, Oncology & Endocrinology, and Others......13
In Vitro Diagnostics (IVD)......14
Table 12: Global In Vitro Diagnostics (IVD) Market by Area (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......14
Table 13: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......15
Table 14: In-Vitro Diagnostic Products Market by Segment in China (2015) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......16
Table 15: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......17
Table 16: In-Vitro Diagnostics (IVD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry, Hematology and Coagulation, Histology and Cytology, Immunoassays, Molecular Diagnostics, Point of Care and Others......18
Table 17: In-Vitro Diagnostics Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and others......19
Molecular Diagnostics (MDx) Test......20
Table 18: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......20
Table 19: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......21
Rapid Testing Equipment......22
Table 20: Market Shares of Leading Rapid Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Alere, Inc. (ALR), Bec World PLC (BEC), Danaher Corporation (DHR), Meridian Bioscience, Inc. (VIVO), OraSure Technologies, Inc. (OSUR), Quidel Corporation (QDEL), and Others......22
Table 21: Market Shares of Leading HIV Rapid Testing Equipment Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Bio-Rad Laboratories, Inc. (BIO), Chembio Diagnostics, Inc. (CEMI), OraSure Technologies, Inc. (OSUR), Trinity Biotech Plc (TRIB), and Others......23
Drugs of Abuse Testing (DOA) Testing Equipment......24
Table 22: Market Shares of Leading Drugs of Abuse Testing (DOA) Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bec World PLC (BEC), Danaher Corporation (DHR), Microgenics Corporation, Roche Holding AG, Siemens AG (SI), and Others......24
HBV/HCV Therapeutics......25
Table 23: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......25